Compared with Wnt inhibitors (XAV-939, ICG-001, and Wnt C59), DY131 showed more potency in GC cells (Supplementary Figs. 11 and 15), indicating that Wnt antagonism via ESRRG is effective in inhibiting GC cell growth. This evidence concerns the gene ESRRG and gastric cancer.